KYIV, UKRAINE, May 21, 2025 /EINPresswire.com/ -- Enamine, the leading provider of chemical compounds and drug discovery services, launches a non-profit organization - Enamine Scientific Research Institute (Enamine SRI). The Institute aims to coordinate scientists in Ukraine supporting research and innovations in chemistry, biology, computer science, and early-stage drug discovery, as well as to help students and young scientists in their development.
Enamine Scientific Research Institute will collaborate with other institutions permanently to share knowledge among the researchers worldwide. Enamine SRI will be led by Prof. Serhii Ryabukhin, Dr., a leading Ukrainian chemist. Enamine will be constantly supporting with all the necessary equipment, lab space, and resources.
โ๐๐ฏ๐ข๐ฎ๐ช๐ฏ๐ฆ ๐ช๐ด ๐ข ๐ด๐ค๐ช๐ฆ๐ฏ๐ต๐ช๐ง๐ช๐ค๐ข๐ญ๐ญ๐บ ๐ฅ๐ณ๐ช๐ท๐ฆ๐ฏ ๐ค๐ฐ๐ฎ๐ฑ๐ข๐ฏ๐บ. ๐๐ฉ๐ณ๐ฐ๐ถ๐จ๐ฉ ๐ต๐ฉ๐ฆ ๐ด๐ค๐ช๐ฆ๐ฏ๐ต๐ช๐ง๐ช๐ค ๐ข๐ฑ๐ฑ๐ณ๐ฐ๐ข๐ค๐ฉ, ๐ธ๐ฆ ๐ฉ๐ข๐ท๐ฆ ๐ฃ๐ฆ๐ฆ๐ฏ ๐ณ๐ฐ๐ถ๐ต๐ช๐ฏ๐ฆ๐ญ๐บ ๐ด๐ฐ๐ญ๐ท๐ช๐ฏ๐จ ๐ต๐ฉ๐ฆ ๐ณ๐ฆ๐ด๐ฆ๐ข๐ณ๐ค๐ฉ ๐จ๐ฐ๐ข๐ญ๐ด ๐ฐ๐ง ๐ฐ๐ถ๐ณ ๐ค๐ญ๐ช๐ฆ๐ฏ๐ต๐ด ๐ข๐ฏ๐ฅ ๐ค๐ฐ๐ญ๐ญ๐ข๐ฃ๐ฐ๐ณ๐ข๐ต๐ฐ๐ณ๐ด. ๐๐ฐ๐ฅ๐ข๐บ, ๐ธ๐ฆ ๐ข๐ณ๐ฆ ๐ฉ๐ข๐ฑ๐ฑ๐บ ๐ต๐ฐ ๐ญ๐ข๐ถ๐ฏ๐ค๐ฉ ๐ข ๐ด๐ฆ๐ฑ๐ข๐ณ๐ข๐ต๐ฆ ๐ฏ๐ฐ๐ฏ-๐ฑ๐ณ๐ฐ๐ง๐ช๐ต ๐ช๐ฏ๐ด๐ต๐ช๐ต๐ถ๐ต๐ช๐ฐ๐ฏ ๐ต๐ฉ๐ข๐ต ๐ธ๐ช๐ญ๐ญ ๐ฃ๐ฆ ๐ง๐ถ๐ญ๐ญ๐บ ๐ง๐ฐ๐ค๐ถ๐ด๐ฆ๐ฅ ๐ฐ๐ฏ ๐ต๐ฉ๐ฆ ๐ด๐ค๐ช๐ฆ๐ฏ๐ต๐ช๐ง๐ช๐ค ๐ข๐ด๐ฑ๐ฆ๐ค๐ต๐ด ๐ฐ๐ง ๐ฎ๐ฐ๐ฅ๐ฆ๐ณ๐ฏ ๐ด๐ค๐ช๐ฆ๐ฏ๐ค๐ฆ. ๐๐ฆ ๐ข๐ต ๐๐ฏ๐ข๐ฎ๐ช๐ฏ๐ฆ ๐ข๐ณ๐ฆ ๐ฑ๐ณ๐ฐ๐ถ๐ฅ ๐ต๐ฉ๐ข๐ต ๐ข๐ง๐ต๐ฆ๐ณ ๐ฎ๐ฐ๐ณ๐ฆ ๐ต๐ฉ๐ข๐ฏ ๐ต๐ฉ๐ณ๐ฆ๐ฆ ๐ฅ๐ฆ๐ค๐ข๐ฅ๐ฆ๐ด ๐ฐ๐ง ๐ฐ๐ถ๐ณ ๐ฉ๐ช๐ด๐ต๐ฐ๐ณ๐บ, ๐ธ๐ฆ ๐ค๐ฐ๐ถ๐ญ๐ฅ ๐ด๐ต๐ฆ๐ฑ ๐ง๐ถ๐ณ๐ต๐ฉ๐ฆ๐ณ ๐ข๐ฏ๐ฅ ๐ค๐ณ๐ฆ๐ข๐ต๐ฆ ๐ข ๐ฏ๐ฆ๐ธ ๐ณ๐ฆ๐ด๐ฆ๐ข๐ณ๐ค๐ฉ ๐ช๐ฏ๐ด๐ต๐ช๐ต๐ถ๐ต๐ช๐ฐ๐ฏ. ๐๐ฆ ๐ข๐ณ๐ฆ ๐ด๐ถ๐ณ๐ฆ ๐ช๐ต ๐ธ๐ช๐ญ๐ญ ๐ฉ๐ฆ๐ญ๐ฑ ๐ด๐ฐ๐ญ๐ท๐ฆ ๐จ๐ญ๐ฐ๐ฃ๐ข๐ญ ๐ด๐ค๐ช๐ฆ๐ฏ๐ต๐ช๐ง๐ช๐ค ๐ค๐ฉ๐ข๐ญ๐ญ๐ฆ๐ฏ๐จ๐ฆ๐ด,โ commented Andrey Tolmachev, Ph.D., Founder and Owner of Enamine.
โ๐๐ฆ ๐ต๐ฉ๐ช๐ฏ๐ฌ ๐ต๐ฉ๐ข๐ต ๐ฏ๐ฐ๐ธ, ๐ช๐ฏ ๐ต๐ฉ๐ฆ ๐ฆ๐ณ๐ข ๐ฐ๐ง ๐ฐ๐ฑ๐ฆ๐ฏ ๐ด๐ค๐ช๐ฆ๐ฏ๐ค๐ฆ ๐ข๐ฏ๐ฅ ๐ค๐ฐ๐ญ๐ญ๐ข๐ฃ๐ฐ๐ณ๐ข๐ต๐ช๐ฐ๐ฏ๐ด, ๐ธ๐ฆ ๐ฌ๐ฆ๐ฆ๐ฑ ๐ถ๐ฑ ๐ธ๐ช๐ต๐ฉ ๐ต๐ฉ๐ฆ ๐ต๐ช๐ฎ๐ฆ๐ด ๐ข๐ฏ๐ฅ ๐ฐ๐ฑ๐ฆ๐ฏ ๐๐ฏ๐ข๐ฎ๐ช๐ฏ๐ฆ ๐๐๐, ๐ข ๐ฏ๐ฐ๐ฏ-๐ฑ๐ณ๐ฐ๐ง๐ช๐ต ๐ฐ๐ณ๐จ๐ข๐ฏ๐ช๐ป๐ข๐ต๐ช๐ฐ๐ฏ, ๐ต๐ฉ๐ข๐ต ๐ด๐ฉ๐ฐ๐ถ๐ญ๐ฅ ๐ฑ๐ณ๐ฐ๐ท๐ช๐ฅ๐ฆ ๐ต๐ฉ๐ฆ ๐ด๐ต๐ณ๐ถ๐ค๐ต๐ถ๐ณ๐ข๐ญ ๐ญ๐ช๐ฏ๐ฌ ๐ฃ๐ฆ๐ต๐ธ๐ฆ๐ฆ๐ฏ ๐ต๐ฉ๐ฆ ๐ค๐ฐ๐ฎ๐ฎ๐ฆ๐ณ๐ค๐ช๐ข๐ญ ๐ข๐ฏ๐ฅ ๐ด๐ค๐ช๐ฆ๐ฏ๐ต๐ช๐ง๐ช๐ค ๐ฑ๐ข๐ณ๐ต๐ด ๐ฐ๐ง ๐๐ฏ๐ข๐ฎ๐ช๐ฏ๐ฆ ๐๐ณ๐ฐ๐ถ๐ฑ. ๐๐ฆ ๐ข๐ณ๐ฆ ๐ฐ๐ฑ๐ฆ๐ฏ ๐ต๐ฐ ๐ฅ๐ช๐ท๐ฆ๐ณ๐ด๐ฆ ๐ด๐ค๐ช๐ฆ๐ฏ๐ต๐ช๐ง๐ช๐ค ๐ค๐ฐ๐ญ๐ญ๐ข๐ฃ๐ฐ๐ณ๐ข๐ต๐ช๐ฐ๐ฏ๐ด,โ added Prof. Serhii Ryabukhin, Dr., Director of Enamine SRI.
๐๐๐จ๐ฎ๐ญ ๐๐ง๐๐ฆ๐ข๐ง๐: Enamine is a scientifically driven integrated discovery Contract Research Organisation with unique partnering opportunities in exploring new chemical space. The company combines access to the in-house produced screening compounds (4.5M in stock) and building blocks (350K in stock) with a comprehensive platform of integrated discovery services to advance and accelerate the efforts in Drug Discovery. For more information, visit: https://enamine.net
Prof. Serhii Ryabukhin, Dr.
Enamine Ltd.
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
